Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Randomized, Double-blind, Placebo-controlled Clinical Trial
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• 18 years or older
• Be able to provide written informed consent
• Diagnosis of PD without active pain and without progressive curvature over the past 3 months (fibrotic phase).
• Penile curvature of 30-95 degrees
• Clearly palpable penile plaque
Locations
Other Locations
Denmark
Herlev and Gentofte University Hospital
RECRUITING
Herlev
Contact Information
Primary
Mikael Heering, MD, Ph.d. student
mikael.heering@regionh.dk
+4538688964
Backup
Mikkel M. Fode, Professor, MD, Ph.d.
mikkel.mejlgaard.fode@regionh.dk
+4538682093
Time Frame
Start Date: 2025-09-20
Estimated Completion Date: 2028-09-01
Participants
Target number of participants: 84
Treatments
Experimental: Platelet Rich Plasma (PRP)
Placebo_comparator: Saline Solution (Placebo)
Related Therapeutic Areas
Sponsors
Leads: Herlev Hospital